Chemosensitizing activity of histone deacetylases inhibitory cyclic hydroxamic acids for combination chemotherapy of lymphatic leukemia

dc.creatorMishchenko D.V.
dc.creatorNeganova M.E.
dc.creatorKlimanova E.N.
dc.creatorSashenkova T.E.
dc.creatorKlochkov S.G.
dc.creatorShevtsova E.F.
dc.creatorVystorop I.V.
dc.creatorTarasov V.V.
dc.creatorChubarev V.N.
dc.creatorSamsonova A.N.
dc.creatorAshraf G.M.
dc.creatorBarreto G.
dc.creatorYarla N.S.
dc.creatorAliev G.
dc.date.accessioned2020-09-02T22:23:03Z
dc.date.accessioned2022-11-08T20:28:13Z
dc.date.available2020-09-02T22:23:03Z
dc.date.available2022-11-08T20:28:13Z
dc.date.created2020-09-02T22:23:03Z
dc.date.issued2018
dc.identifier18, 4, 365-371
dc.identifier15680096
dc.identifierhttps://hdl.handle.net/20.500.12728/5350
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5146746
dc.languageen
dc.publisherBentham Science Publishers B.V.
dc.subjectChemosensitizing property
dc.subjectCombination chemotherapy
dc.subjectHDAC inhibitory activity
dc.subjectHistone deacetylases
dc.subjectHydroxamic acid
dc.subjectLymphatic leukemia
dc.subjectcyclophosphamide
dc.subjectferrozine
dc.subjecthistone deacetylase inhibitor
dc.subjecthydroxamic acid
dc.subjecttrichostatin A
dc.subjectantineoplastic agent
dc.subjecthistone deacetylase inhibitor
dc.subjecthydroxamic acid
dc.subjectacute toxicity
dc.subjectanimal experiment
dc.subjectantineoplastic activity
dc.subjectArticle
dc.subjectchemosensitivity
dc.subjectcontrolled study
dc.subjectdrug structure
dc.subjectdrug therapy
dc.subjectiron chelation
dc.subjectLD50
dc.subjectlipid peroxidation
dc.subjectlipophilicity
dc.subjectlymphatic leukemia
dc.subjectmale
dc.subjectmetastasis inhibition
dc.subjectnonhuman
dc.subjectoxidative stress
dc.subjectrat
dc.subjectanimal
dc.subjectchemistry
dc.subjectHeLa cell line
dc.subjecthuman
dc.subjectlymphatic leukemia
dc.subjectmetabolism
dc.subjectmouse
dc.subjectpathology
dc.subjectAnimals
dc.subjectAntineoplastic Combined Chemotherapy Protocols
dc.subjectHeLa Cells
dc.subjectHistone Deacetylase Inhibitors
dc.subjectHumans
dc.subjectHydroxamic Acids
dc.subjectLeukemia, Lymphoid
dc.subjectMale
dc.subjectMice
dc.subjectRats
dc.titleChemosensitizing activity of histone deacetylases inhibitory cyclic hydroxamic acids for combination chemotherapy of lymphatic leukemia
dc.typeArticle


Este ítem pertenece a la siguiente institución